Adastra Holdings Ltd. (XTXXF) stock
XTXXFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 20-F on May 17, 2023
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
Adastra price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Adastra's price to sales ratio was 0.0× on Oct 19, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.0× to 221.6×, with a median of 8.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 0.0× | −0.0 |
| 2025 | Dec 31, 2025 | 0.1× | −0.0 |
| 2024 | Dec 31, 2024 | 0.1× | −8.3 |
| 2023 | Dec 29, 2023 | 8.3× | −31.3 |
| 2022 | Dec 30, 2022 | 39.7× | −146.3 |
| 2021 | Dec 31, 2021 | 186.0× | – |
See a number that looks wrong?